Stay updated with breaking news from Access Vascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Access Vascular Inc. (AVI) closed a $22 million series C funding round that it plans to use principally to increase production capacity for its Mimix hydrophilic biomaterial vascular access devices. The company’s catheters are designed to evade identification as foreign bodies, reduce bacterial adhesion and eliminate catheter-related thrombus development.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
"The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical, Inc. (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), Nipro Medical
During the forecast period. Growth in the vascular access device market can primarily be attributed to factors such as the growing prevalence of lifestyle...
/PRNewswire/ -- In the near future, the Vascular Access Device (VAD) industry is poised for transformative advancements, driven by cutting-edge technologies...